ICON Public Limited Company Profile Avatar - Palmy Investing

ICON Public Limited Company

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, manage…
Medical - Diagnostics & Research
IE, Dublin [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 33% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 8.79 67.62 62.16
Graham Fair Price -6.18 76.38 81.41
PEG 218.61 -2.67 0.84
Price/Book 15.06 2.90 2.52
Price/Cash Flow 47.94 91.34 61.74
Prices/Earnings 35.60 36.54 26.94
Price/Sales 16.09 13.10 11.29
Price/FCF 47.94 91.34 61.74
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -1.35 0.22 0.23
Operating Margin 5.04 0.14 0.13
ROA -13.69 0.01 0.01
ROE 0.02 0.02 -15.15
ROIC 0.02 0.02 -19.81
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.07 -0.05 -37.93
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.04 0.06 51.83
EPS QOQ 0.32 -0.14 -57.44
FCF QOQ 0.21 -0.21 -1.50
Revenue QOQ < 0.005 0.01 115.34
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) < 0.005 -0.16 285510356.96
Days Sales Outstanding (DSO) 126.29 129.50 2.54
Inventory Turnover 1595460000.00 -558.81 -100.00
Debt/Capitalization 0.29 0.27 -7.34
Quick Ratio 1.16 1.16 -0.39
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 112.15 114.23 1.85
Cash 4.61 4.82 4.50
Capex -0.62 -0.33 47.27
Free Cash Flow 4.58 3.63 -20.78
Revenue 25.08 25.31 0.95
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.21 1.21 -0.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 8.23 7.17 -12.89
Naive Interpretation Member
06 - Financial Health · Weak
End of ICLR's Analysis
CIK: 1060955 CUSIP: G4705A100 ISIN: IE0005711209 LEI: - UEI: -
Secondary Listings
ICLR has no secondary listings inside our databases.